Changyuan Li – Trademark Portfolio

Entity Type: 01

Changyuan Li holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include FAOLORE. The owner is based in Longshan Hunan.

No 4,6 Zu Longdongcun Tongchexiang

Longshan Hunan 416800 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FAOLORE
FAOLORE
Registered 2025
POMUTRE
POMUTRE
Abandoned 2018

Trademark Classifications

Changyuan Li's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Changyuan Li have?

Changyuan Li has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned.

What trademark classes does Changyuan Li file in?

Changyuan Li files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Changyuan Li's most well-known trademarks?

Changyuan Li's registered trademark portfolio includes well-known marks such as FAOLORE. These are among 1 currently registered trademark in the portfolio.

What is Changyuan Li's trademark registration success rate?

Changyuan Li has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.